Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
- PMID: 36049810
- DOI: 10.1016/j.jacc.2022.05.057
Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardias: Is the Debate Over?
Comment in
-
Reply: Survive the Threat of Slow VT.J Am Coll Cardiol. 2022 Sep 6;80(10):e79-e80. doi: 10.1016/j.jacc.2022.06.024. J Am Coll Cardiol. 2022. PMID: 36049811 No abstract available.
Comment on
-
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050. J Am Coll Cardiol. 2022. PMID: 35422240 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources